InvestorsHub Logo
Followers 82
Posts 12404
Boards Moderated 0
Alias Born 07/25/2008

Re: None

Friday, 08/02/2019 3:08:47 PM

Friday, August 02, 2019 3:08:47 PM

Post# of 81
Stemline Theraputics STML

Stemline Therapeutics (NASDAQ:STML): Q2 GAAP EPS of -$0.42 beats by $0.14.
Revenue of $13M beats by $6.5M.

https://seekingalpha.com/pr/17591900-stemline-therapeutics-reports-second-quarter-2019-financial-results